Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Letermovir“
Suchtreffer
Begriffe & Kennungen
Prevymis · 4.5 · Additional effects of other products on letermovir relevant when combined with cyclosporine
Eintrag öffnenPrevymis · 4.5 · Anti-arrhythmic medicinal products amiodarone Interaction not studied. Letermovir may increase the plasma Expe
Eintrag öffnenPrevymis · 4.5 · Co-administration of letermovir (with or without cyclosporine) with strong and moderate inducers of transporte
Eintrag öffnenPrevymis · 4.5 · Co-administration of letermovir (with or without cyclosporine) with strong and moderate inducers of transporte
Eintrag öffnenPrevymis · 4.5 · Co-administration of letermovir (with or without cyclosporine) with strong and moderate inducers of transporte
Eintrag öffnenPrevymis · 4.5 · Effect of letermovir on other medicinal products
Eintrag öffnenPrevymis · 4.5 · Effect of letermovir on other medicinal products
Eintrag öffnenPrevymis · 4.5 · Effect of letermovir on other medicinal products
Eintrag öffnenPrevymis · 4.5 · Effect of other medicinal products on letermovir
Eintrag öffnenPrevymis · 4.5 · Effect of other medicinal products on letermovir
Eintrag öffnenPrevymis · 4.5 · Effect of other medicinal products on letermovir
Eintrag öffnenPrevymis · 4.5 · General information about differences in exposure between different letermovir treatment regimens
Eintrag öffnenPrevymis · 4.5 · General information about differences in exposure between different letermovir treatment regimens
Eintrag öffnenPrevymis · 4.5 · General information about differences in exposure between different letermovir treatment regimens
Eintrag öffnenPrevymis · 4.5 · If dose adjustments of concomitant medicinal products are made due to treatment with letermovir, doses should
Eintrag öffnenPrevymis · 4.5 · If dose adjustments of concomitant medicinal products are made due to treatment with letermovir, doses should
Eintrag öffnenPrevymis · 4.5 · If dose adjustments of concomitant medicinal products are made due to treatment with letermovir, doses should
Eintrag öffnenPrevymis · 4.5 · In vitro, letermovir is an inhibitor of CYP3A, CYP2C8, CYP2B6, BCRP, UGT1A1, OATP2B1, and OAT3 at in vivo rele
Eintrag öffnenPrevymis · 4.5 · In vitro, letermovir is an inhibitor of CYP3A, CYP2C8, CYP2B6, BCRP, UGT1A1, OATP2B1, and OAT3 at in vivo rele
Eintrag öffnenPrevymis · 4.5 · In vitro, letermovir is an inhibitor of CYP3A, CYP2C8, CYP2B6, BCRP, UGT1A1, OATP2B1, and OAT3 at in vivo rele
Eintrag öffnen